New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated

Santiago Roura1, Carolina Gálvez-Montón, Josep M Pujal

  • 1ICREC Research Program, Germans Trias i Pujol Health Science Research Institute, Badalona, Spain.

Atherosclerosis
|October 1, 2013
PubMed

Insights

In idiopathic dilated cardiomyopathy (IDCM), the heart

Area of Science:

  • Cardiovascular Biology
  • Cellular and Molecular Medicine

Background:

  • Idiopathic dilated cardiomyopathy (IDCM) is characterized by impaired myocardial vascularization.
  • The underlying causes, including cellular responses and vascularization demand, remain unclear.

Purpose of the Study:

  • To investigate the role of circulating angiogenic-supportive cells and myocardial vascularization in IDCM.
  • To explore the mechanisms behind vascular derangements in IDCM.

Main Methods:

  • Comparison of left ventricle (LV) tissue from IDCM hearts and control hearts.
  • Isolation and analysis of peripheral pro-angiogenic cells from IDCM patients and healthy volunteers.
  • Assessment of stromal cell-derived factor (SDF)-1α, integrin-linked kinase (ILK), and lipid raft localization.

Main Results:

  • Increased ILK levels and activity in IDCM hearts, with SDF-1α co-localizing in lipid rafts.
  • Pro-angiogenic cells from IDCM patients showed reduced SDF-1-mediated migration and decreased ILK/ERK signaling.
  • No difference in myocardial vascularization competency or CXCR-4 surface levels was observed.

Conclusions:

  • Myocardial vascularization capacity is not impaired in IDCM.
  • Dysfunctional SDF-1-mediated cell migration, linked to ILK/ERK signaling, may hinder endothelial recovery in IDCM.
  • Findings offer insights into lipid raft function and potential therapeutic targets for IDCM.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...